Current Report Filing (8-k)
November 03 2016 - 4:59PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): NOVEMBER 3, 2016
Commission File Number: 0-24260
AMEDISYS, INC.
(Exact
Name of Registrant as specified in its Charter)
|
|
|
Delaware
|
|
11-3131700
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
3854 American Way, Suite A, Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)
(225) 292-2031 or (800) 467-2662
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
SECTION 2 FINANCIAL INFORMATION
ITEM 2.02.
|
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
|
On November 3, 2016, Amedisys, Inc. (we,
us, our or the Company) issued a press release announcing our financial results for the three and nine-month periods ended September 30, 2016. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
The information presented in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall
not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, unless we specifically state that the
information is to be considered filed under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act.
SECTION 7 REGULATION FD
ITEM 7.01.
|
REGULATION FD DISCLOSURE
|
Item 2.02 of this Current Report on Form 8-K is incorporated herein by
reference.
In addition, a copy of the supplemental slides which will be discussed during the Companys earnings call at 11:00 a.m. ET on Friday,
November 4, 2016 is attached to this report as Exhibit 99.2 and incorporated herein by reference.
The information presented in Item 7.01 of
this Current Report on Form 8-K shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, unless we specifically state that the information is to be considered
filed under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Act or the Exchange Act.
SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01.
|
FINANCIAL STATEMENTS AND EXHIBITS
|
(d) Exhibits.
|
|
|
99.1
|
|
Press release dated November 3, 2016, announcing the Companys financial results for the three and nine-month periods ended September 30, 2016 (furnished only)
|
|
|
99.2
|
|
Supplemental slides provided in connection with the third quarter 2016 earnings call of the Company (furnished only)
|
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
AMEDISYS, INC.
|
(Registrant)
|
|
|
By:
|
|
/s/ Scott G. Ginn
|
|
|
|
|
Scott G. Ginn
|
|
|
Senior Vice President of Finance and Accounting
|
|
|
(Principal Accounting Officer)
|
DATE: November 3, 2016
Exhibit Index
|
|
|
Exhibit
No.
|
|
Description
|
|
|
99.1
|
|
Press release dated November 3, 2016, announcing the Companys financial results for the three and nine-month periods ended September 30, 2016 (furnished only)
|
|
|
99.2
|
|
Supplemental slides provided in connection with the third quarter 2016 earnings call of the Company (furnished only)
|
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024